Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer|Advanced Nonsmall Cell Lung Cancer|Advanced Gastric Cancer
Interventions: DRUG: XMT-1522
Sponsor: Mersana Therapeutics